BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35734415)

  • 21. The change of drug utilization in China's public healthcare institutions under the "4 + 7" centralized drug procurement policy: Evidence from a natural experiment in China.
    Lu J; Long H; Shen Y; Wang J; Geng X; Yang Y; Mao Z; Li J
    Front Pharmacol; 2022; 13():923209. PubMed ID: 36081942
    [No Abstract]   [Full Text] [Related]  

  • 22. Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.
    Tu HA; Bos JH; Woerdenbag HJ; Visser ST; Wilschut JC; van Assen S; de Jong-van den Berg LT; Postma MJ
    Clin Ther; 2010 Jan; 32(1):133-44. PubMed ID: 20171419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis.
    Huang C; Ung COL; Wushouer H; Bai L; Li X; Guan X; Shi L
    Int J Health Policy Manag; 2022 Aug; 11(8):1489-1495. PubMed ID: 34273922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of National Centralised Drug Procurement policy on the use of policy-related original and generic drugs in China.
    Yang Y; Hu R; Geng X; Mao L; Wen X; Wang Z; Hao S; Cui D; Mao Z
    Int J Health Plann Manage; 2022 May; 37(3):1650-1662. PubMed ID: 35132676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis.
    Wang N; Yang Y; Xu L; Mao Z; Cui D
    BMC Public Health; 2021 Oct; 21(1):1883. PubMed ID: 34663282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series study.
    Cai L; Tao T; Li H; Zhang Z; Zhang L; Li X
    J Glob Health; 2022 Dec; 12():11016. PubMed ID: 36527382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of a National Stewardship Policy on the Usage Patterns of Key Monitoring Drugs in a Tertiary Teaching Hospital: An Interrupted Time Series Analysis.
    Li H; McIver DJ; Ji W; Du J; Zhao H; Jia X; Zhai Y; Xue X
    Front Pharmacol; 2022; 13():847353. PubMed ID: 35250599
    [No Abstract]   [Full Text] [Related]  

  • 28. The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis.
    Wen X; Yin S; Cui L; Mao L; Lin Z; Yaermaimaiti Z; Geng X; Li Y; Yang Y; Cui D; Mao Z
    Front Public Health; 2021; 9():718013. PubMed ID: 34760861
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
    Rong X; Yin J; Duan S; Sun Q; Babar ZU
    BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.
    Chen Y; Ji X; Xiao H; Unger JM; Cai Y; Mao Z; Yeung K
    Front Pharmacol; 2021; 12():804237. PubMed ID: 35815118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does China improve social welfare after implementing the national volume-based procurement?
    Wang H; Huo YT; Zhuang Q
    Front Pharmacol; 2023; 14():1178026. PubMed ID: 37886133
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study.
    Wushouer H; Luo Z; Guan X; Shi L
    Int J Health Policy Manag; 2022 Feb; 11(2):218-223. PubMed ID: 32702801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China.
    Tang Y; Liu C; Zhang Z; Zhang X
    Cost Eff Resour Alloc; 2018; 16():1. PubMed ID: 29371833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
    Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
    N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.
    Lim YS; Gwak GY; Choi J; Lee YS; Byun KS; Kim YJ; Yoo BC; Kwon SY; Lee HC
    J Hepatol; 2019 Jul; 71(1):35-44. PubMed ID: 30876946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicines used in mental, neurological and substance use disorders in Gauteng, South Africa: A secondary analysis of the 2017-2018 provincial pharmaceutical database, Part 1.
    Bouwer JC; Govender S; Robertson LJ
    S Afr J Psychiatr; 2021; 27():1552. PubMed ID: 33604075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impacts of National Drug Price Negotiation on Expenditure, Volume, and Availability of Targeted Anti-Cancer Drugs in China: An Interrupted Time Series Analysis.
    Sun Y; Zhu Z; Zhang J; Han P; Qi Y; Wang X; Yang L
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011.
    Luo J; Oliveira MA; Ramos MB; Maia A; Osorio-de-Castro CG
    BMC Public Health; 2014 Apr; 14():367. PubMed ID: 24735589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Public procurement of hepatitis C medicines in Brazil from 2005 to 2015.
    Chaves GC; Castro CGSO; Oliveira MA
    Cien Saude Colet; 2017 Aug; 22(8):2527-2538. PubMed ID: 28793069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.